Position in SHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,101,655
+$5,561,049 QoQ
Shares Held
425,499
+976.7% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Verition Fund Management LLC holds $55,485,979 across 17 Diagnostics & Research names. SHC ranks #2 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
21,462 | $10,549,216 | |
| 2 | SHC |
Sotera Health Co
This page
|
425,499 | $6,101,655 | |
| 3 | A |
Agilent Technologies, Inc.
|
50,510 | $5,757,129 | |
| 4 | WAT |
Waters Corp /De/
|
19,028 | $5,666,538 | |
| 5 | ICLR |
Icon PLC
|
42,343 | $4,685,676 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
7,440 | $3,572,613 | |
| 7 | RDNT |
RadNet, Inc.
|
55,691 | $3,112,569 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
17,989 | $3,103,102 |
All Filings in SHC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,101,655 | 425,499 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $540,606 | 39,518 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $285,636 | 17,104 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $341,428 | 28,764 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $283,147 | 23,576 | Shares | Sole | 2024-05-14 | |
| 2022-09-30 | $419,982 | 61,581 | Shares | Sole | 2023-01-18 | |
| 2022-03-31 | $3,693,203 | 170,508 | Shares | Sole | 2022-06-02 | |
| 2021-03-31 | $224,914 | 9,011 | Shares | Sole | 2021-05-18 | |
| No filing history on record for this holder in this stock. | ||||||